Introductory Remarks by Corresponding Member of the Russian Academy of Sciences, Professor Vladimir F. Semiglazov

Most read articles by the same author(s)

• Tengiz T. Tabagua, Valerii Evgenievich Levchenko, Victoria V. Mortada, Roman. S. Pesotsky Roman. S., Nicolai Amirov, Aleksandr S. Emelyanov, Mahmud M. Mortada, Pavel I. Krzhivitsky, Vladimir F. Semiglazov, Petr V. Krivorotko, The The Role of Axillary Reverse Mapping during Sentinel Lymph Node Biopsy in Breast Cancer Patients , Voprosy onkologii: Vol. 70 No. 3 (2024)
• Elena K. Zhiltsova, Petr V. Krivorotko , Darya G. Ulrich, Diana A. Enaldieva, Alexander S. Emelyanov, Tengiz T. Tabagua, Larisa P. Gigolaeva, Nikolay S. Amirov, Roman S. Pesotsky, Viktoriia V., Alexander V. Komyakhov, Sergey S. Yerechshenko, Kirill S. Nikolaev, Yana I. Bondarchuk, Valerii E. Levchenko, Vladimir F. Semiglazov, The Need for Neoadjuvant Chemotherapy in Patients with Luminal B HER2-Negative Breast Cancer , Voprosy onkologii: Vol. 71 No. 3 (2025)
• Tatiana I. Sevostyanova, Tatiana Yu. Semiglazova, Sergey N. Novikov, Zhanna V. Bryantseva, Irina A. Akulova, Sheyda. R Abdullaeva, Olga I. Ponasenko, Maria S. Kobysheva, Yulduz Z. Tatarkhanova, Kirill A. Nizovtsev, Alexandra D. Gavrilova, Veronika V. Klimenko, Larisa V. Filatova, Boris S. Kasparov, Rashida V. Orlova, Mark I. Gluzman, Anna E. Protasova, Nadezhda V. Kryukova, Elena M. Pavlova, Maria I. Dolgaleva, Eugenia Y. Zubareva, Andrey P. Galin, Vladislav V. Semiglazov, Petr V. Krivorotko, Vladimir F. Semiglazov, Sergey I. Gvozdarev, Alexey M. Belyaev , Stereotactic Radiotherapy in Combination with the Immunoconjugate Trastuzumab Emtansine in Patients with HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study , Voprosy onkologii: Vol. 72 No. 3 (2026)
• Vladimir F. Semiglazov, Introductory Remarks by Corresponding Member of the Russian Academy of Sciences, Professor Vladimir F. Semiglazov , Voprosy onkologii: Vol. 71 No. 3 (2025)